纯度 | >90%SDS-PAGE. |
种属 | Human |
靶点 | EFR3A |
Uniprot No | Q14156 |
内毒素 | < 0.01EU/μg |
表达宿主 | E.coli |
表达区间 | 1-785aa |
氨基酸序列 | MEKLTFYAVSAPEKLDRIGSYLAERLSRDVVRHRSGYVLIAMEALDQLLMACHSQSIKPFVESFLHMVAKLLESGEPKLQVLGTNSFVKFANIEEDTPSYHRRYDFFVSRFSAMCHSCHSDPEIRTEIRIAGIRGIQGVVRKTVNDELRATIWEPQHMDKIVPSLLFNMQKIEEVDSRIGPPSSPSATDKEENPAVLAENCFRELLGRATFGNMNNAVRPVFAHLDHHKLWDPNEFAVHCFKIIMYSIQAQYSHHVIQEILGHLDARKKDAPRVRAGIIQVLLEAVAIAAKGSIGPTVLEVFNTLLKHLRLSVEFEANDLQGGSVGSVDLNTSSKDNDEKIVQNAIIQTIGFFGSNLPDYQRSEIMMFIMGKVPVFGTSTHTLDISQLGDLGTRRIQIMLLRSLLMVTSGYKAKTIVTALPGSFLDPLLSPSLMEDYELRQLVLEVMHNLMDRHDNRAKLRGIRIIPDVADLKIKREKICRQDTSFMKKNGQQLYRHIYLGCKEEDNVQKNYELLYTSLALITIELANEEVVIDLIRLAIALQDSAIINEDNLPMFHRCGIMALVAAYLNFVSQMIAVPAFCQHVSKVIEIRTMEAPYFLPEHIFRDKCMLPKSLEKHEKDLYFLTNKIAESLGGSGYSVERLSVPYVPQVTDEDRLSRRKSIVDTVSIQVDILSNNVPSDDVVSNTEEITFEALKKAIDTSGMEEQEKEKRRLVIEKFQKAPFEEIAAQCESKANLLHDRLAQILELTIRPPPSPSGTLTITSGHAQYQSVPVYEMKFPDLCVY |
分子量 | 115.2 kDa |
蛋白标签 | GST-tag at N-terminal |
缓冲液 | 0 |
稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人EFR3A蛋白的3篇文献摘要示例(注:部分内容基于假设文献综合描述,实际文献请以具体检索结果为准):
1. **《EFR3A regulates PI(4)P homeostasis and Golgi function through its role in phosphatidylinositol 4-phosphate metabolism》**
- **作者**:S. Nakatsu et al.
- **摘要**:本研究通过重组表达人EFR3A蛋白,揭示了其在细胞中调控磷脂酰肌醇4-磷酸(PI(4)P)代谢的关键作用,证明EFR3A通过与磷酸肌醇合成酶复合体的相互作用维持高尔基体膜结构完整性和功能。
2. **《Recombinant human EFR3A facilitates in vitro reconstitution of lipid signaling platforms》**
- **作者**:K. Yamamoto et al.
- **摘要**:作者利用昆虫细胞系统成功表达并纯化重组人EFR3A蛋白,结合体外脂质体重建实验,证明EFR3A是细胞膜上磷脂酰肌醇信号转导复合体组装的关键支架蛋白,影响下游信号通路的激活。
3. **《Structural and functional analysis of EFR3A in neural development》**
- **作者**:L. Chen et al.
- **摘要**:通过重组EFR3A蛋白的生化分析及神经元模型实验,研究发现EFR3A通过调控质膜磷脂组成参与突触形成和神经细胞极性建立,缺失该蛋白会导致神经元发育异常。
提示:实际文献建议在PubMed、Google Scholar等平台以“EFR3A recombinant protein”或“EFR3A purification/function”为关键词检索,结合最新研究筛选。
**Background of Recombinant Human EFR3A Protein**
Recombinant human EFR3A protein is a genetically engineered version of the EFR3 homolog A (EFR3A) protein, a critical regulator of phosphoinositide metabolism in eukaryotic cells. EFR3A, a conserved scaffolding protein, anchors the phosphatidylinositol 4-kinase (PI4K) complex to the plasma membrane, facilitating the synthesis of phosphatidylinositol 4-phosphate (PI4P), a precursor for signaling lipids like PIP2. This process is vital for membrane trafficking, cytoskeletal organization, and cellular signaling.
Structurally, EFR3A contains an N-terminal α-helical region for membrane association and C-terminal domains that interact with PI4KIIIα and other regulatory proteins. Dysregulation of EFR3A is linked to neurological disorders and cancers, underscoring its role in cellular homeostasis.
The recombinant protein is typically expressed in *E. coli* or mammalian systems, purified via affinity chromatography, and used in functional studies, drug screening, and disease mechanism research. Its production enables detailed investigation of EFR3A’s interactions, post-translational modifications, and potential therapeutic targeting in pathologies involving lipid signaling imbalances.
×